术后局部复发和远处转移的精确诊断被公认为是个体化治疗以提高生存率的关键。
An accurate diagnosis of postoperative local recurrence and distant metastasis is crucial for prescribing optimal individualized management and thus elevating the survival rate.
结论放化疗综合治疗N2、N3期鼻咽癌有助于提高短、中期生存率，减少局部复发和远处转移。
Conclusion Radiotherapy with chemotherapy can increase the survival rates and decrease the distant metasis in patients with N2, N3 stage nasopharyngeal carcinoma.
放疗联合胸腺肽治疗能够明显提高鼻咽癌患者的生存率，降低远处转移率。
The combined radiotherapy with thymic peptide can highly improve the survival rate of patients with nasopharyngeal carcinoma and lower its distant metastasis rate.
结论化疗加放疗能明显提高患者的生存率，降低远处转移率。
Conclusion Radiotherapy and chemotherapy concurrently can obviously increase the survival rate and decrease the rate of the distant metastasis.
结论鼻咽癌颈部淋巴结转移切取活检可增加其远处转移率，降低生存率。
Conclusion Cervical incisional biopsy increases distant metastatic rate and decreased survival rate for NPC.
回顾性分析两组患者的局部复发和远处转移例数以及2年生存率。
Two groups received the same adjuvant postoperative chemotherapy scheme. 2-year survival, local recurrence and distant metastasis were analyzed.
免疫组化研究对于判断涎腺导管癌早期局部复发、远处转移和生存率有所帮助。
Immunohistochemical study was linked to the early local disease recurrence, distant disease metastasis and survival rates.
随访内容包括患者一年、三年、五年的生存率、局部复发、远处转移、美容效果等。
The follow-up including 1,3,5 years survival rates, local recurrence, distant metastasis and cosmetic effect.
虽然各种诊治措施不断进展，但是甲状腺癌的远期生存率仍然没有得到明显的提高，肿瘤细胞的侵袭和远处转移是其治疗失败的主要原因。
Despite recent advancements in diagnosis and treatment, the long-term survival rate has undergone little improvement in the recent years, which is attributed mainly to tumor invasion and metastasis.
虽然各种诊治措施不断进展，但是甲状腺癌的远期生存率仍然没有得到明显的提高，肿瘤细胞的侵袭和远处转移是其治疗失败的主要原因。
Despite recent advancements in diagnosis and treatment, the long-term survival rate has undergone little improvement in the recent years, which is attributed mainly to tumor invasion and metastasis.
应用推荐